Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

453

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Bipolar Disorder
Interventions
DRUG

Licarbazepine

Trial Locations (22)

10003

Investigational Site, New York

11201

Invetigational Site, Brooklyne

11516

Investigational Site, Cedarhurst

30308

Investigational Site, Atlanta

33432

Investigational Site, Boca Raton

43210

Investigational Site, Columbus

45267

Investigational Site, Cincinnati

46222

Investigational Site, Indianapolis

53227

Investigational Site, West Allis

60435

Investigational Site, Joliet

60640

Investigational Site, Chicago

63104

Investigational Site, St Louis

64133

Investigational Site, Kansas City

66606

Investigational Site, Topeka

72201

Investigational Site, Little Rock

77401

Investigational Site, Bellaire

90660

Investigational Site, Pico Rivera

92108

Investigational Site, San Diego

92126

Investigational Site, San Diego

92868

Investigational Site, Orange

98004

Investigational Site, Bellevue

02903

Investigational Site, Providence

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY